Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, TDS

Clarius Mobile Health Announces Clarius AI: Collective Intelligence Ultrasound Platform


CHICAGO, Nov. 21, 2018 /PRNewswire/ -- Clarius Mobile Health is pleased to announce a new collective intelligence ultrasound platform at this year's Radiological Society of North America (RSNA) annual meeting. The Clarius AI solution focuses on data and image quality, ease of data collection, and a collaborative platform for both physicians and researchers to label and augment acquired images.

The Clarius AI solution focuses on data and image quality, ease of data collection, and a collaborative platform for both physicians and researchers to label and augment acquired images.

"One of the most challenging aspects of AI in healthcare is the ability to capture quality data that focuses on specific clinical needs," said Dr. Reza Zahiri, Director of Innovation at Clarius. "We're accelerating AI development by making it easy to acquire and label large amounts of data with our scanners and cloud platform."

The labeled data, which are created by medical experts, can then be fed into various AI frameworks such as TensorFlow or PyTorch for training. The trained models would eventually be deployed as clinical solutions for the Clarius app and Clarius Cloud and made available to medical experts around the world.

"AI within ultrasound imaging is still relatively new," said Kris Dickie, Vice President of Research and Development at Clarius. "It's a big step forward to be able to acquire and manage massive amounts of data. We've started internal projects and partnerships with key collaborators in radiology and point-of-care medicine to build these new tools."

Compared to other imaging modalities, ultrasound has the advantage of being real-time. However, it's challenging to run images through trained algorithms at high frames rates. Clarius has leveraged and developed key technologies to run AI algorithms in real-time, where users will be able to simply download an updated app and get access to new AI features.

"When it comes to using clinical data from thousands of patients for AI, data security and data privacy are always concerns," said Dr. Zahiri. "At Clarius, we take this seriously. Clarius Cloud is HIPAA-compliant and has built-in security and scrubbing techniques from the ground up, so that data is automatically anonymized when being accessed for labeling and algorithm training. Clarius also follows the HITRUST CSF framework for regulatory compliance and risk management."

The Clarius AI platform will be available to any clinical research group or medical professional interested in developing their own AI tools. The system will enable the collective intelligence of clinicians, researchers and industry to solve complex clinical problems, and bring AI solutions to a growing demographic of ultrasound users.

About Clarius Mobile Health

Clarius Mobile Health was founded with the mission of making ultrasound available to all clinicians. It has developed portable ultrasound scanners that connect wirelessly to iOS® and Androidtm devices. Clarius scanners offer high-resolution ultrasound images that are as good as the best traditional point-of-care systems. Clarius is committed to improving the quality of patient care everywhere. For more information, visit www.clarius.com.

Media Contact

Roderick Lee, Marketing Content Manager 
Email: [email protected] Tel: 1-604-671-4563

SOURCE Clarius Mobile Health Corp


These press releases may also interest you

at 04:28
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:13
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...

at 03:05
Surge has just closed its second round of funding, raising ?7.5 million. The round was led by Eurazeo with the participation of Kima, Teampact, and MH Innov', as well as the support of historical funds Boutique Venture, HCVC, and 50 Partners Santé....

at 03:00
CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who...



News published on and distributed by: